25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

JBCHEPHARM (JB Chemicals & Pharmaceuticals Limited) Stock Analysis
Buy, Hold or Sell?

Let's analyze JB Chemicals & Pharmaceuticals Limited together

I guess you are interested in JB Chemicals & Pharmaceuticals Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – JB Chemicals & Pharmaceuticals Limited’s Financial Insights
  • 📈 Technical Analysis (TA) – JB Chemicals & Pharmaceuticals Limited’s Price Targets

I'm going to help you getting a better view of JB Chemicals & Pharmaceuticals Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about JB Chemicals & Pharmaceuticals Limited

I send you an email if I find something interesting about JB Chemicals & Pharmaceuticals Limited.

1. Quick Overview

1.1. Quick analysis of JB Chemicals & Pharmaceuticals Limited (30 sec.)










1.2. What can you expect buying and holding a share of JB Chemicals & Pharmaceuticals Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.71
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR220.00
Expected worth in 1 year
INR350.72
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR191.47
Return On Investment
11.4%

For what price can you sell your share?

Current Price per Share
INR1,679.80
Expected price per share
INR1,680 - INR1,903
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of JB Chemicals & Pharmaceuticals Limited (5 min.)




Live pricePrice per Share (EOD)
INR1,679.80
Intrinsic Value Per Share
INR360.69 - INR1,241.11
Total Value Per Share
INR580.69 - INR1,461.11

2.2. Growth of JB Chemicals & Pharmaceuticals Limited (5 min.)




Is JB Chemicals & Pharmaceuticals Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$401.6m$342m$59.6m14.9%

How much money is JB Chemicals & Pharmaceuticals Limited making?

Current yearPrevious yearGrowGrow %
Making money$77.1m$64.6m$12.5m16.2%
Net Profit Margin16.8%15.9%--

How much money comes from the company's main activities?

2.3. Financial Health of JB Chemicals & Pharmaceuticals Limited (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of JB Chemicals & Pharmaceuticals Limited?

Welcome investor! JB Chemicals & Pharmaceuticals Limited's management wants to use your money to grow the business. In return you get a share of JB Chemicals & Pharmaceuticals Limited.

First you should know what it really means to hold a share of JB Chemicals & Pharmaceuticals Limited. And how you can make/lose money.

Speculation

The Price per Share of JB Chemicals & Pharmaceuticals Limited is INR1,680. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of JB Chemicals & Pharmaceuticals Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in JB Chemicals & Pharmaceuticals Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR220.00. Based on the TTM, the Book Value Change Per Share is INR32.68 per quarter. Based on the YOY, the Book Value Change Per Share is INR28.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR15.19 per quarter.
Based on historical numbers we can estimate the returns while holding a share of JB Chemicals & Pharmaceuticals Limited.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.490.0%0.490.0%0.410.0%0.410.0%0.370.0%0.310.0%
Usd Book Value Change Per Share0.380.0%0.380.0%0.330.0%0.320.0%0.300.0%0.370.0%
Usd Dividend Per Share0.180.0%0.180.0%0.120.0%0.130.0%0.110.0%0.090.0%
Usd Total Gains Per Share0.560.0%0.560.0%0.450.0%0.450.0%0.410.0%0.460.0%
Usd Price Per Share18.98-18.98-19.30-20.45-18.89-14.94-
Price to Earnings Ratio38.38-38.38-46.58-53.33-53.49-46.52-
Price-to-Total Gains Ratio33.89-33.89-42.90-47.44-48.05-46.65-
Price to Book Ratio7.37-7.37-8.81-9.53-10.17-8.59-
Price-to-Total Gains Ratio33.89-33.89-42.90-47.44-48.05-46.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share19.65366
Number of shares50
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.180.11
Usd Book Value Change Per Share0.380.30
Usd Total Gains Per Share0.560.41
Gains per Quarter (50 shares)28.0020.38
Gains per Year (50 shares)112.0181.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
13676102226072
27115321443120154
310722932665180236
414230643887239318
5178382550108299400
6213459662130359482
7249535774152419564
8284612886173479646
9320688998195539728
103557651110217598810

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.01.00.085.7%6.01.00.085.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of JB Chemicals & Pharmaceuticals Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--32.67932.6790%28.385+15%27.654+18%25.571+28%31.429+4%
Book Value Per Share--220.001220.0010%187.322+17%188.753+17%163.900+34%143.810+53%
Current Ratio--3.0413.0410%2.135+42%2.644+15%3.150-3%3.354-9%
Debt To Asset Ratio--0.1970.1970%0.268-27%0.256-23%0.227-13%0.216-9%
Debt To Equity Ratio--0.2450.2450%0.366-33%0.348-30%0.300-18%0.281-13%
Dividend Per Share--15.18915.1890%10.059+51%11.141+36%9.258+64%8.094+88%
Enterprise Value--244754322777.600244754322777.6000%246703530745.600-1%262766450796.800-7%244164865644.160+0%192777041173.486+27%
Eps--42.26542.2650%35.412+19%34.650+22%31.469+34%26.739+58%
Ev To Sales Ratio--6.2476.2470%7.081-12%7.584-18%8.448-26%7.125-12%
Free Cash Flow Per Share--50.11950.1190%34.554+45%25.248+99%11.693+329%11.530+335%
Free Cash Flow To Equity Per Share--50.11950.1190%34.554+45%25.248+99%8.799+470%5.236+857%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1241.106----------
Intrinsic Value_10Y_min--360.687----------
Intrinsic Value_1Y_max--46.722----------
Intrinsic Value_1Y_min--18.041----------
Intrinsic Value_3Y_max--199.556----------
Intrinsic Value_3Y_min--70.205----------
Intrinsic Value_5Y_max--423.733----------
Intrinsic Value_5Y_min--139.505----------
Market Cap262147921638.400+3%253158922777.600253158922777.6000%257411530745.600-2%272715717463.467-7%251921374844.160+0%199294041459.200+27%
Net Profit Margin--0.1680.1680%0.159+6%0.152+10%0.168+0%0.159+6%
Operating Margin----0%-0%0.062-100%0.125-100%0.138-100%
Operating Ratio--1.1161.1160%1.1220%0.827+35%0.951+17%1.025+9%
Pb Ratio7.635+3%7.3747.3740%8.805-16%9.527-23%10.172-28%8.595-14%
Pe Ratio39.745+3%38.38238.3820%46.579-18%53.327-28%53.489-28%46.516-17%
Price Per Share1679.800+3%1622.2001622.2000%1649.450-2%1747.517-7%1614.270+0%1277.043+27%
Price To Free Cash Flow Ratio33.516+3%32.36732.3670%47.736-32%-46.879+245%-22.635+170%-5.029+116%
Price To Total Gains Ratio35.092+3%33.88933.8890%42.904-21%47.443-29%48.045-29%46.648-27%
Quick Ratio--1.8371.8370%1.234+49%1.500+22%1.800+2%1.996-8%
Return On Assets--0.1540.1540%0.138+12%0.136+13%0.151+2%0.145+7%
Return On Equity--0.1920.1920%0.189+2%0.182+5%0.195-1%0.185+4%
Total Gains Per Share--47.86847.8680%38.445+25%38.796+23%34.830+37%39.523+21%
Usd Book Value--401698440.000401698440.0000%342029610.000+17%344643000.000+17%299263601.520+34%262580739.943+53%
Usd Book Value Change Per Share--0.3820.3820%0.332+15%0.324+18%0.299+28%0.368+4%
Usd Book Value Per Share--2.5742.5740%2.192+17%2.208+17%1.918+34%1.683+53%
Usd Dividend Per Share--0.1780.1780%0.118+51%0.130+36%0.108+64%0.095+88%
Usd Enterprise Value--2863625576.4982863625576.4980%2886431309.724-1%3074367474.323-7%2856728928.037+0%2255491381.730+27%
Usd Eps--0.4940.4940%0.414+19%0.405+22%0.368+34%0.313+58%
Usd Free Cash Flow--91511550.00091511550.0000%63091629.900+45%46100133.300+99%21350438.460+329%21052448.486+335%
Usd Free Cash Flow Per Share--0.5860.5860%0.404+45%0.295+99%0.137+329%0.135+335%
Usd Free Cash Flow To Equity Per Share--0.5860.5860%0.404+45%0.295+99%0.103+470%0.061+857%
Usd Market Cap3067130683.169+3%2961959396.4982961959396.4980%3011714909.724-2%3190773894.323-7%2947480085.677+0%2331740285.073+27%
Usd Price Per Share19.654+3%18.98018.9800%19.299-2%20.446-7%18.887+0%14.941+27%
Usd Profit--77170860.00077170860.0000%64657710.000+19%63266190.000+22%57459425.400+34%48823170.686+58%
Usd Revenue--458404830.000458404830.0000%407649060.000+12%411506550.000+11%350568061.740+31%306447728.786+50%
Usd Total Gains Per Share--0.5600.5600%0.450+25%0.454+23%0.408+37%0.462+21%
 EOD+4 -4MRQTTM+0 -0YOY+30 -73Y+28 -105Y+30 -810Y+30 -8

3.3 Fundamental Score

Let's check the fundamental score of JB Chemicals & Pharmaceuticals Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1539.745
Price to Book Ratio (EOD)Between0-17.635
Net Profit Margin (MRQ)Greater than00.168
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.837
Current Ratio (MRQ)Greater than13.041
Debt to Asset Ratio (MRQ)Less than10.197
Debt to Equity Ratio (MRQ)Less than10.245
Return on Equity (MRQ)Greater than0.150.192
Return on Assets (MRQ)Greater than0.050.154
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of JB Chemicals & Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1,708.950
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About JB Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

Fundamental data was last updated by Penke on 2025-06-21 22:35:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit JB Chemicals & Pharmaceuticals Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 16.8% means that ₹0.17 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 16.8%. The company is making a huge profit. +2
  • The TTM is 16.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.8%TTM16.8%0.0%
TTM16.8%YOY15.9%+1.0%
TTM16.8%5Y16.8%+0.0%
5Y16.8%10Y15.9%+0.9%
4.3.1.2. Return on Assets

Shows how efficient JB Chemicals & Pharmaceuticals Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 15.4% Return on Assets means that JB Chemicals & Pharmaceuticals Limited generated ₹0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 15.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 15.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.4%TTM15.4%0.0%
TTM15.4%YOY13.8%+1.6%
TTM15.4%5Y15.1%+0.3%
5Y15.1%10Y14.5%+0.6%
4.3.1.3. Return on Equity

Shows how efficient JB Chemicals & Pharmaceuticals Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 19.2% Return on Equity means JB Chemicals & Pharmaceuticals Limited generated ₹0.19 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 19.2%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 19.2%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ19.2%TTM19.2%0.0%
TTM19.2%YOY18.9%+0.3%
TTM19.2%5Y19.5%-0.3%
5Y19.5%10Y18.5%+1.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of JB Chemicals & Pharmaceuticals Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient JB Chemicals & Pharmaceuticals Limited is operating .

  • Measures how much profit JB Chemicals & Pharmaceuticals Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y12.5%-12.5%
5Y12.5%10Y13.8%-1.3%
4.3.2.2. Operating Ratio

Measures how efficient JB Chemicals & Pharmaceuticals Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.12 means that the operating costs are ₹1.12 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 1.116. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.116. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.116TTM1.1160.000
TTM1.116YOY1.122-0.005
TTM1.1165Y0.951+0.165
5Y0.95110Y1.025-0.074
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of JB Chemicals & Pharmaceuticals Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if JB Chemicals & Pharmaceuticals Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.04 means the company has ₹3.04 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 3.041. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.041. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.041TTM3.0410.000
TTM3.041YOY2.135+0.906
TTM3.0415Y3.150-0.109
5Y3.15010Y3.354-0.204
4.4.3.2. Quick Ratio

Measures if JB Chemicals & Pharmaceuticals Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.84 means the company can pay off ₹1.84 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 1.837. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.837. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.837TTM1.8370.000
TTM1.837YOY1.234+0.602
TTM1.8375Y1.800+0.037
5Y1.80010Y1.996-0.197
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of JB Chemicals & Pharmaceuticals Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of JB Chemicals & Pharmaceuticals Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.20 means that JB Chemicals & Pharmaceuticals Limited assets are financed with 19.7% credit (debt) and the remaining percentage (100% - 19.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.197. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.197. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.197TTM0.1970.000
TTM0.197YOY0.268-0.071
TTM0.1975Y0.227-0.031
5Y0.22710Y0.216+0.011
4.5.4.2. Debt to Equity Ratio

Measures if JB Chemicals & Pharmaceuticals Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 24.5% means that company has ₹0.24 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.245. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.245. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.245TTM0.2450.000
TTM0.245YOY0.366-0.121
TTM0.2455Y0.300-0.055
5Y0.30010Y0.281+0.019
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings JB Chemicals & Pharmaceuticals Limited generates.

  • Above 15 is considered overpriced but always compare JB Chemicals & Pharmaceuticals Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 38.38 means the investor is paying ₹38.38 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 39.745. Based on the earnings, the company is overpriced. -1
  • The MRQ is 38.382. Based on the earnings, the company is overpriced. -1
  • The TTM is 38.382. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD39.745MRQ38.382+1.363
MRQ38.382TTM38.3820.000
TTM38.382YOY46.579-8.198
TTM38.3825Y53.489-15.107
5Y53.48910Y46.516+6.973
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 33.516. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 32.367. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 32.367. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD33.516MRQ32.367+1.149
MRQ32.367TTM32.3670.000
TTM32.367YOY47.736-15.369
TTM32.3675Y-22.635+55.002
5Y-22.63510Y-5.029-17.606
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of JB Chemicals & Pharmaceuticals Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 7.37 means the investor is paying ₹7.37 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 7.635. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.374. Based on the equity, the company is overpriced. -1
  • The TTM is 7.374. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.635MRQ7.374+0.262
MRQ7.374TTM7.3740.000
TTM7.374YOY8.805-1.432
TTM7.3745Y10.172-2.799
5Y10.17210Y8.595+1.578
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets42,737,800
Total Liabilities8,404,600
Total Stockholder Equity34,333,200
 As reported
Total Liabilities 8,404,600
Total Stockholder Equity+ 34,333,200
Total Assets = 42,737,800

Assets

Total Assets42,737,800
Total Current Assets19,227,400
Long-term Assets23,510,400
Total Current Assets
Cash And Cash Equivalents 1,150,900
Short-term Investments 3,459,400
Net Receivables 8,153,800
Inventory 5,289,500
Other Current Assets 1,168,300
Total Current Assets  (as reported)19,227,400
Total Current Assets  (calculated)19,221,900
+/- 5,500
Long-term Assets
Property Plant Equipment 6,566,400
Goodwill 574,600
Intangible Assets 13,171,400
Long-term Assets Other 155,200
Long-term Assets  (as reported)23,510,400
Long-term Assets  (calculated)20,467,600
+/- 3,042,800

Liabilities & Shareholders' Equity

Total Current Liabilities6,323,300
Long-term Liabilities2,081,300
Total Stockholder Equity34,333,200
Total Current Liabilities
Short Long Term Debt 138,000
Accounts payable 4,107,200
Other Current Liabilities 222,800
Total Current Liabilities  (as reported)6,323,300
Total Current Liabilities  (calculated)4,468,000
+/- 1,855,300
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt140,900
Long-term Liabilities Other 19,000
Long-term Liabilities  (as reported)2,081,300
Long-term Liabilities  (calculated)159,900
+/- 1,921,400
Total Stockholder Equity
Total Stockholder Equity (as reported)34,333,200
Total Stockholder Equity (calculated)0
+/- 34,333,200
Other
Capital Stock155,700
Common Stock Shares Outstanding 155,677
Net Invested Capital 34,471,200
Net Working Capital 12,904,100
Property Plant and Equipment Gross 6,566,400



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
17,910,005
18,135,611
22,381,152
26,074,022
35,538,700
39,941,300
42,737,800
42,737,80039,941,30035,538,70026,074,02222,381,15218,135,61117,910,00500
   > Total Current Assets 
7,948,902
10,472,125
10,511,522
10,731,509
15,526,024
12,748,550
15,280,300
18,533,500
19,227,400
19,227,40018,533,50015,280,30012,748,55015,526,02410,731,50910,511,52210,472,1257,948,902
       Cash And Cash Equivalents 
0
0
353,968
290,079
286,855
565,441
769,300
882,200
1,150,900
1,150,900882,200769,300565,441286,855290,079353,96800
       Short-term Investments 
0
0
3,606,499
3,338,126
6,649,748
1,062
2,159,300
3,846,900
3,459,400
3,459,4003,846,9002,159,3001,0626,649,7483,338,1263,606,49900
       Net Receivables 
2,759,122
3,073,200
3,248,376
3,454,262
3,890,191
5,556,868
5,757,974
6,869,188
8,153,800
8,153,8006,869,1885,757,9745,556,8683,890,1913,454,2623,248,3763,073,2002,759,122
       Inventory 
2,001,686
2,137,314
2,437,577
2,746,697
3,474,468
4,099,611
4,304,900
5,025,100
5,289,500
5,289,5005,025,1004,304,9004,099,6113,474,4682,746,6972,437,5772,137,3142,001,686
       Other Current Assets 
753,380
1,065,465
756,803
663,263
807,147
1,980,856
2,275,100
1,903,100
1,168,300
1,168,3001,903,1002,275,1001,980,856807,147663,263756,8031,065,465753,380
   > Long-term Assets 
0
0
7,414,252
7,408,327
6,855,128
13,325,472
20,258,400
21,407,800
23,510,400
23,510,40021,407,80020,258,40013,325,4726,855,1287,408,3277,414,25200
       Property Plant Equipment 
6,010,328
5,811,134
5,595,066
5,841,966
5,696,550
5,668,159
5,764,200
6,348,800
6,566,400
6,566,4006,348,8005,764,2005,668,1595,696,5505,841,9665,595,0665,811,1346,010,328
       Goodwill 
0
0
531,400
531,400
574,592
574,592
574,600
574,600
574,600
574,600574,600574,600574,592574,592531,400531,40000
       Intangible Assets 
0
0
233,775
300,924
321,052
6,713,944
13,222,800
13,884,600
13,171,400
13,171,40013,884,60013,222,8006,713,944321,052300,924233,77500
       Long-term Assets Other 
0
0
0
1
10,689
-90,321
33,700
48,500
155,200
155,20048,50033,700-90,32110,6891000
> Total Liabilities 
0
0
3,080,748
3,755,708
4,246,853
4,687,893
10,735,200
10,708,000
8,404,600
8,404,60010,708,00010,735,2004,687,8934,246,8533,755,7083,080,74800
   > Total Current Liabilities 
2,812,084
2,751,153
2,441,838
3,132,685
3,452,737
3,837,156
5,544,500
8,682,300
6,323,300
6,323,3008,682,3005,544,5003,837,1563,452,7373,132,6852,441,8382,751,1532,812,084
       Short Long Term Debt 
0
0
257,977
320,361
326,446
263,150
1,650,200
3,335,000
138,000
138,0003,335,0001,650,200263,150326,446320,361257,97700
       Accounts payable 
989,771
1,103,950
1,173,746
1,679,656
1,869,234
2,244,797
2,386,400
3,563,100
4,107,200
4,107,2003,563,1002,386,4002,244,7971,869,2341,679,6561,173,7461,103,950989,771
       Other Current Liabilities 
1,230,209
1,199,025
970,343
1,037,202
943,671
1,005,519
236,500
242,000
222,800
222,800242,000236,5001,005,519943,6711,037,202970,3431,199,0251,230,209
   > Long-term Liabilities 
0
0
648,391
627,248
794,116
850,737
5,190,700
2,025,700
2,081,300
2,081,3002,025,7005,190,700850,737794,116627,248648,39100
       Capital Lease Obligations Min Short Term Debt
0
0
0
61,822
123,433
282,438
242,100
205,200
140,900
140,900205,200242,100282,438123,43361,822000
       Long-term Liabilities Other 
0
0
22,029
59,684
49,322
31,664
25,000
17,000
19,000
19,00017,00025,00031,66449,32259,68422,02900
       Deferred Long Term Liability 
0
0
1,576
0
0
0
0
0
0
0000001,57600
> Total Stockholder Equity
0
0
14,801,224
14,354,893
18,097,248
21,341,230
24,803,500
29,233,300
34,333,200
34,333,20029,233,30024,803,50021,341,23018,097,24814,354,89314,801,22400
   Common Stock
169,640
167,140
160,473
154,564
154,564
154,564
0
0
0
000154,564154,564154,564160,473167,140169,640
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
-31,506
24,879
-5,698
-41,056
80,810
745,658
0
0
0
000745,65880,810-41,056-5,69824,879-31,506



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue39,179,900
Cost of Revenue-13,165,500
Gross Profit26,014,40026,014,400
 
Operating Income (+$)
Gross Profit26,014,400
Operating Expense-30,571,900
Operating Income8,608,000-4,557,500
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense30,571,9000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-117,300
Other Finance Cost-0
Net Interest Income-117,300
 
Pretax Income (+$)
Operating Income8,608,000
Net Interest Income-117,300
Other Non-Operating Income Expenses0
Income Before Tax (EBT)8,873,9008,608,000
EBIT - interestExpense = -117,300
6,595,800
6,713,100
Interest Expense117,300
Earnings Before Interest and Taxes (EBIT)08,991,200
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax8,873,900
Tax Provision-2,278,100
Net Income From Continuing Ops6,595,8006,595,800
Net Income6,595,800
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0117,300
 

Technical Analysis of JB Chemicals & Pharmaceuticals Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of JB Chemicals & Pharmaceuticals Limited. The general trend of JB Chemicals & Pharmaceuticals Limited is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine JB Chemicals & Pharmaceuticals Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. JB Chemicals & Pharmaceuticals Limited Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of JB Chemicals & Pharmaceuticals Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1,890 < 1,891 < 1,903.

The bearish price targets are: 1,769 > 1,749 > 1,680.

Know someone who trades $JBCHEPHARM? Share this with them.👇

JB Chemicals & Pharmaceuticals Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of JB Chemicals & Pharmaceuticals Limited. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

JB Chemicals & Pharmaceuticals Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Moving Average Convergence/Divergence (MACD) ChartJB Chemicals & Pharmaceuticals Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of JB Chemicals & Pharmaceuticals Limited. The current adx is .

JB Chemicals & Pharmaceuticals Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Relative Strength Index (RSI) ChartJB Chemicals & Pharmaceuticals Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Stochastic Oscillator ChartJB Chemicals & Pharmaceuticals Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Commodity Channel Index (CCI) ChartJB Chemicals & Pharmaceuticals Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Chande Momentum Oscillator (CMO) ChartJB Chemicals & Pharmaceuticals Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Williams %R ChartJB Chemicals & Pharmaceuticals Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Average True Range (ATR) ChartJB Chemicals & Pharmaceuticals Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily On-Balance Volume (OBV) ChartJB Chemicals & Pharmaceuticals Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Money Flow Index (MFI) ChartJB Chemicals & Pharmaceuticals Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for JB Chemicals & Pharmaceuticals Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

JB Chemicals & Pharmaceuticals Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of JB Chemicals & Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1,708.950
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of JB Chemicals & Pharmaceuticals Limited with someone you think should read this too:
  • Are you bullish or bearish on JB Chemicals & Pharmaceuticals Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about JB Chemicals & Pharmaceuticals Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about JB Chemicals & Pharmaceuticals Limited

I send you an email if I find something interesting about JB Chemicals & Pharmaceuticals Limited.


Comments

How you think about this?

Leave a comment

Stay informed about JB Chemicals & Pharmaceuticals Limited.

Receive notifications about JB Chemicals & Pharmaceuticals Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.